2,049
Views
17
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR

Hunting for abscopal and bystander effects: clinical exploitation of non-targeted effects induced by partial high-single-dose irradiation of the hypoxic tumour segment in oligometastatic patients

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Slavisa Tubin, Mansoor M. Ahmed & Seema Gupta. (2018) Radiation and hypoxia-induced non-targeted effects in normoxic and hypoxic conditions in human lung cancer cells. International Journal of Radiation Biology 94:3, pages 199-211.
Read now

Articles from other publishers (16)

Qiuxia Lu, Weisi Yan, Alan Zhu, Slavisa Tubin, Waleed F. Mourad & Jun Yang. (2024) Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio. Clinical and Translational Radiation Oncology 44, pages 100691.
Crossref
Mickael Mathieu, Sadna Budhu, Prerna R. Nepali, James Russell, Simon N. Powell, John Humm, Joseph O. Deasy & Adriana Haimovitz-Friedman. (2023) Activation of STING in Response to Partial-Tumor Radiation Exposure. International Journal of Radiation Oncology*Biology*Physics 117:4, pages 955-965.
Crossref
Hyunkyung Kim, Eunju Lee, Haeun Cho, Eunji Kim, Won Il Jang, Kwangmo Yang, Yoon-Jin Lee, Tae-Jin Kim & Mi-Sook Kim. (2023) Five-Day Spacing of Two Fractionated Ablative Radiotherapies Enhances Antitumor Immunity. International Journal of Radiation Oncology*Biology*Physics.
Crossref
Tubin Slavisa, R. Horsman Michael, S. Sørensen Brita, Gupta Seema & M. M. Khan. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 20 .
Steven J. HattenJrJr, Eric J. Lehrer, Jenn Liao, Congzhou M. Sha, Daniel M. Trifiletti, Shankar Siva, Sean M. McBride, David Palma, Sheldon L. Holder & Nicholas G. Zaorsky. (2022) A Patient-Level Data Meta-analysis of the Abscopal Effect. Advances in Radiation Oncology 7:3, pages 100909.
Crossref
Slavisa Tubin, Piero Fossati, Antonio Carlino, Giovanna Martino, Joanna Gora, Markus Stock & Eugen Hug. (2022) Novel Carbon Ion and Proton Partial Irradiation of Recurrent Unresectable Bulky Tumors (Particle-PATHY): Early Indication of Effectiveness and Safety. Cancers 14:9, pages 2232.
Crossref
Irma Telarovic, Roland H. Wenger & Martin Pruschy. (2021) Interfering with Tumor Hypoxia for Radiotherapy Optimization. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Slavisa Tubin, Seema Gupta, Michael Grusch, Helmuth H. Popper, Luka Brcic, Martin L. Ashdown, Samir N. Khleif, Barbara Peter-Vörösmarty, Martin Hyden, Simone Negrini, Piero Fossati & Eugen Hug. (2020) Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY). Cancers 13:1, pages 50.
Crossref
Qingting Huang, Yun Sun, Weiwei Wang, Lien-Chun Lin, Yangle Huang, Jing Yang, Xiaodong Wu, Lin Kong & Jiade Jay Lu. (2020) Biological Guided Carbon-Ion Microporous Radiation to Tumor Hypoxia Area Triggers Robust Abscopal Effects as Open Field Radiation. Frontiers in Oncology 10.
Crossref
Slavisa Tubin, Weisi Yan, Waleed F Mourad, Piero Fossati & Mohammad K Khan. (2020) The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches. Future Oncology 16:16, pages 1137-1151.
Crossref
Slavisa Tubin, Martin Ashdown & Branislav Jeremic. (2019) Time-synchronized immune-guided SBRT partial bulky tumor irradiation targeting hypoxic segment while sparing the peritumoral immune microenvironment. Radiation Oncology 14:1.
Crossref
Slavisa Tubin, Mohammad K. Khan, Gerardo Salerno, Waleed F. Mourad, Weisi Yan & Branislav Jeremic. (2019) Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment. Radiation Oncology 14:1.
Crossref
Slavisa Tubin, Helmut H. Popper & Luka Brcic. (2019) Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects. Radiation Oncology 14:1.
Crossref
Pavel N. Lobachevsky, Jessica Ventura, Lina Giannakandropoulou, Helen Forrester, Jason S. Palazzolo, Nicole M. Haynes, Andrew W. Stevenson, Christopher J. Hall, Joel Mason, Gerasimos Pollakis, Ioannis S. Pateras, Vassilis Gorgoulis, Georgia I. Terzoudi, John A. Hamilton, Carl N. Sprung, Alexandros G. Georgakilas & Olga A. Martin. (2019) A Functional Immune System Is Required for the Systemic Genotoxic Effects of Localized Irradiation. International Journal of Radiation Oncology*Biology*Physics 103:5, pages 1184-1193.
Crossref
Zachary S. Buchwald, Jacob Wynne, Tahseen H. Nasti, Simeng Zhu, Waleed F. Mourad, Weisi Yan, Seema Gupta, Samir N. Khleif & Mohammad K. Khan. (2018) Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation. Frontiers in Oncology 8.
Crossref
Rodolfo Chicas-Sett, Ignacio Morales-Orue, Delvys Rodriguez-Abreu & Pedro Lara-Jimenez. (2018) Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review. Clinical and Translational Radiation Oncology 9, pages 5-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.